drugset / Trial / NCT07476144

Nordic Spirit Pouch Nicotine Pharmacokinetics Abuse Liability

NCT07476144

Phase 1 Recruiting 55 enrolled JT International SA ICON Clinical Research · collab
RandomizedCrossoverOpen-labelOther

Summary

Nicotine pharmacokinetics and subjective effects of 9 Nordic Spirit Nicotine Pouch Products in adult cigarette smokers: A controlled, randomized, cross-over study with a balanced incomplete block design.

Timeline

Start
2026-01-08
Primary completion
2026-04
Completion
2026-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 3 mg Other
Subject Nicotine Unknown 4 mg Other
Subject Nicotine Unknown 6 mg Other
Subject Nicotine Unknown 9 mg Other
Subject Nicotine Unknown 12 mg Other

Indications

No indication recorded.